SCHEMBL9688352

SCHEMBL9688352

COc1ccc(CCN(C)C)c2[nH]c(=O)[nH]c12

nearest known ligand 0.49

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.49
HTR1A P08908 2/20 0.44
HTR2A P28223 2/20 0.42
ACHE P22303 1/20 0.41
AOC3 Q16853 1/20 0.41
CYP19A1 P11511 1/20 0.39
NQO2 P16083 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9689724 0.85 HTR6 (0.49) HTR6HTR1AHTR2AACHEAOC3
SCHEMBL9689118 0.84 DRD2 (0.40)
SCHEMBL9688896 0.81 HTR2A (0.47) HTR6HTR2ACYP19A1NQO2
SCHEMBL9688894 0.78 HTR1A (0.44) HTR6HTR1AHTR2A
SCHEMBL9687943 0.72 HTR6 (0.46) HTR6HTR1AHTR2AACHEAOC3
SCHEMBL9687954 0.72 HTR6 (0.43) HTR6HTR1AHTR2AACHEAOC3
SCHEMBL9689679 0.71 HTR6 (0.45) HTR6HTR1AHTR2AAOC3
SCHEMBL9689684 0.71 NOS1 (0.43) HTR6HTR1AHTR2AAOC3
SCHEMBL9689134 0.71 HTR6 (0.50) HTR6HTR1AHTR2AAOC3
SCHEMBL9689621 0.71 HTR6 (0.47) HTR6HTR1AHTR2AAOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0189473-B1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS SCHERING AKTIENGESELLSCHAFT (DE) 1992-05-27 EP disclosed
US-4958026-A HYPOTENSIVE AGENTS SCHERING AKTIENGESLLSCHAFT (DE) 1990-09-18 US disclosed
EP-0189473-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS. SCHERING AG (DE) 1986-08-06 EP disclosed
WO-1986001204-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS SCHERING AKTIENGESELLSCHAFT (DE) 1986-02-27 WO disclosed